1. A phase II study of ET-743/trabectedin (‘Yondelis’) for patients with advanced gastrointestinal stromal tumours;Blay;Eur J Cancer,2004
2. Phase II study of 3-hour infusion of ET-743 in pretreated adult and pediatric patients with advanced/recurrent sarcomas-preliminary results from the Sendo and Italian Sarcoma Group;Casanova;Med Pediatr Oncol,2002
3. Phase II evaluation of 3-hr infusion ET-743 in patients with recurrent sarcomas;Dileo;Proc Am Soc Clin Oncol,2002
4. Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy;Garcia-Carbonero;J Clin Oncol,2004
5. Phase II study of ecteinascidin-743 (ET-743) given by 3-hour IV infusion in patients (pts) with soft tissue sarcomas (STS) failing prior chemotherapies;George;Proc Am Soc Clin Oncol,2002